Leerink Partnrs Expects Weaker Earnings for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Stock analysts at Leerink Partnrs dropped their Q1 2025 earnings estimates for DENTSPLY SIRONA in a research note issued on Wednesday, April 9th. Leerink Partnrs analyst M. Cherny now expects that the medical instruments supplier will post earnings per share of $0.29 for the quarter, down from their prior forecast of $0.32. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA's Q2 2025 earnings at $0.43 EPS, Q3 2025 earnings at $0.48 EPS, Q4 2025 earnings at $0.53 EPS, FY2025 earnings at $1.73 EPS, FY2026 earnings at $1.94 EPS, FY2027 earnings at $2.28 EPS and FY2028 earnings at $2.60 EPS.

XRAY has been the subject of several other research reports. Mizuho reduced their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their target price for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Finally, Evercore ISI reiterated an "in-line" rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Thirteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, DENTSPLY SIRONA currently has an average rating of "Hold" and an average price target of $22.58.

Remove Ads

DENTSPLY SIRONA Stock Down 4.1 %

DENTSPLY SIRONA stock traded down $0.53 during midday trading on Friday, reaching $12.55. The stock had a trading volume of 3,114,936 shares, compared to its average volume of 2,949,488. The stock has a market capitalization of $2.50 billion, a P/E ratio of -6.06, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The firm's fifty day simple moving average is $16.09 and its 200-day simple moving average is $19.01. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA has a 1-year low of $12.16 and a 1-year high of $31.75.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 5.10%. DENTSPLY SIRONA's payout ratio is -14.07%.

Insider Buying and Selling

In other news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.52% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds have recently modified their holdings of XRAY. MML Investors Services LLC grew its stake in DENTSPLY SIRONA by 2.1% in the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier's stock valued at $803,000 after purchasing an additional 620 shares during the period. Y Intercept Hong Kong Ltd increased its holdings in DENTSPLY SIRONA by 28.8% during the third quarter. Y Intercept Hong Kong Ltd now owns 30,823 shares of the medical instruments supplier's stock worth $834,000 after buying an additional 6,899 shares during the last quarter. Barclays PLC raised its position in DENTSPLY SIRONA by 21.8% in the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after acquiring an additional 54,920 shares during the period. M&T Bank Corp boosted its stake in DENTSPLY SIRONA by 5.6% in the third quarter. M&T Bank Corp now owns 39,079 shares of the medical instruments supplier's stock valued at $1,058,000 after acquiring an additional 2,062 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at approximately $261,000. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.